Ondine Biomedical Inc. NPV (CDI) (OBI) RNS Announcements

Add to Alert list
Date Time Source Announcement
18 Apr 2023 11:00 AM
RNS
Ondine Phase 2 results presented at ECCMID 2023
17 Apr 2023 07:00 AM
RNS
Progress Update
05 Apr 2023 03:00 PM
RNS
Ondine food-safe photodisinfection update
07 Mar 2023 07:00 AM
RNS
Lux Vitae advocates Steriwave for COVID prevention
03 Mar 2023 07:00 AM
RNS
Ottawa hospital presents Steriwave study results
22 Feb 2023 07:00 AM
RNS
Grant of Share Options
31 Jan 2023 12:01 PM
RNS
Ondine's APDT reduces SARS-CoV-2 infectivity
17 Jan 2023 10:04 AM
RNS
TR-1: Notification of major holdings
17 Jan 2023 09:30 AM
RNS
New photodisinfection study published
13 Jan 2023 04:40 PM
RNS
Second Price Monitoring Extn
13 Jan 2023 04:35 PM
RNS
Price Monitoring Extension
30 Dec 2022 12:31 PM
RNS
Appointment of Nominated Adviser
12 Dec 2022 07:00 AM
RNS
Steriwave receives regulatory approval in Mexico
05 Dec 2022 07:00 AM
RNS
Ondine receives funding for meat photodisinfection
02 Dec 2022 06:25 PM
RNS
Ondine receives funding for meat photodisinfection
02 Dec 2022 07:00 AM
RNS
Ondine reports full results from Phase 2 trial
21 Nov 2022 07:00 AM
RNS
Ondine appoints Spanish distributer for Steriwave
07 Nov 2022 09:02 AM
RNS
Ondine cuts COVID-19 rate in food processing plant
04 Nov 2022 07:00 AM
RNS
PDMR Dealing
31 Oct 2022 11:18 AM
RNS
Ondine CTO receives Lifetime Achievement Award
28 Oct 2022 07:00 AM
RNS
PDMR Dealing
19 Oct 2022 12:07 PM
RNS
Ondine presents new efficacy data against MRSA
19 Oct 2022 11:36 AM
RNS
SteriwaveT cuts SSI risk by 47% at major hospital
11 Oct 2022 07:00 AM
RNS
Investor Presentation
27 Sep 2022 07:00 AM
RNS
Interim results for the six months to 30 June 2022
23 Sep 2022 09:00 AM
RNS
The Ottawa Hospital pilots nasal disinfection
20 Sep 2022 09:34 AM
RNS
New research presented on photodisinfection
07 Sep 2022 12:30 PM
RNS
Ondine's photodisinfection kills ESKAPE pathogens
06 Sep 2022 07:00 AM
RNS
Ondine reports successful US Phase 2 trial data
31 Aug 2022 10:49 AM
RNS
Nature reports Ondine therapy suppresses COVID-19
16 Aug 2022 07:00 AM
RNS
Ondine appoints RBC and Singer as joint brokers
08 Aug 2022 10:02 AM
RNS
Ondine completes US Phase II trial recruitment
26 Jul 2022 07:00 AM
RNS
Completion of Nominated Adviser due diligence
22 Jul 2022 07:00 AM
RNS
Issue of Equity
19 Jul 2022 07:00 AM
RNS
Ondine completes successful SARS-CoV-2 trial
08 Jun 2022 07:00 AM
RNS
Result of AGM
07 Jun 2022 07:00 AM
RNS
Posting of annual report
19 May 2022 07:00 AM
RNS
Full Year Results to 31 December 2021
17 May 2022 07:00 AM
RNS
Notice of AGM
10 May 2022 10:30 AM
RNS
WHO calls for better infection prevention
27 Apr 2022 04:30 PM
RNS
Appointment of Nominated Adviser
05 Apr 2022 07:00 AM
RNS
Photodisinfection effective against SARS-CoV-2
21 Feb 2022 07:00 AM
RNS
Grant of Options and PDMR Dealing
07 Feb 2022 07:00 AM
RNS
Ondine treats first patients in Phase 2 FDA trial
20 Dec 2021 07:00 AM
RNS
Ondine and University of Navarra initiate clinical
15 Dec 2021 07:00 AM
RNS
Ondine Biomedical appoints Professor Trevor Jones
07 Dec 2021 07:00 AM
RNS
Ondine Biomedical appoints new Board of Directors
06 Dec 2021 07:00 AM
RNS
Ondine Biomedical announces AIM market listing
UK 100

Latest directors dealings